An Investigator Initiated Eight Week Two Center Open-Label Pilot Study of the Tolerability and Safety of Oral UT-15C (Treprostinil Diethanolamine) SR Tablets in Patients With Critical Limb Ischemia (CLI) and Ischaemic Rest Pain

Trial Profile

An Investigator Initiated Eight Week Two Center Open-Label Pilot Study of the Tolerability and Safety of Oral UT-15C (Treprostinil Diethanolamine) SR Tablets in Patients With Critical Limb Ischemia (CLI) and Ischaemic Rest Pain

Completed
Phase of Trial: Phase II

Latest Information Update: 27 Feb 2017

At a glance

  • Drugs Treprostinil (Primary)
  • Indications Peripheral ischaemia
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 26 Jun 2014 Status changed from unconfirmed to completed.
    • 25 Jun 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top